SCHEMBL19082089

SCHEMBL19082089

c1ccc(-c2c3ccccc3c(-c3ccc4sc5c(ccc6sc7c8ccccc8ccc7c65)c4c3)c3ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.45
CYP1B1 Q16678 5/20 0.45
CYP1A2 P05177 3/20 0.39
LIMK1 P53667 1/20 0.36
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
F9 P00740 2/20 0.33
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
ALOX5 P09917 2/20 0.33
PTPN1 P18031 1/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
PIM1 P11309 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
MAPK9 P45984 1/20 0.32
MAPK14 Q16539 1/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082139 0.99 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2LIMK1ESR1
SCHEMBL19082211 0.96 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2LIMK1ESR1
SCHEMBL17246873 0.96 CYP1A1 (0.48) CYP1A1CYP1B1CYP1A2LIMK1ESR1
SCHEMBL17247141 0.94 CYP1A1 (0.47) CYP1A1CYP1B1CYP1A2LIMK1ESR1
SCHEMBL19082088 0.92 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2LIMK1ESR1
SCHEMBL19082093 0.92 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2LIMK1ESR1
SCHEMBL19082120 0.92 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2LIMK1ESR1
SCHEMBL17945420 0.92 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2LIMK1ESR1
SCHEMBL17246872 0.92 CYP1A1 (0.48) CYP1A1CYP1B1CYP1A2LIMK1ESR1
SCHEMBL27335480 0.92 CYP1A1 (0.48) CYP1A1CYP1B1CYP1A2LIMK1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.